Childhood Cancer Therapeutic Catalyst supports academic researchers in collaborative early drug discovery to advance novel therapeutics for children and young people with cancer.
Cancer Research UK's CDD supports the development of novel cancer agents from preclinical stages to early clinical trials with expert resources, not monetary funding.
Discovery Programme Award supports established researchers pursuing ambitious basic and early-stage translational cancer research to address fundamental questions and deepen understanding of cancer biology.
Discovery Programme Foundation Award supports mid-career researchers developing independent cancer biology programmes to deepen understanding of cancer and build scientific leadership.
Accelerating Hope: Clinical Trials for Hard-to-Treat Cancers Award supports researchers conducting clinical trials for hard-to-treat childhood cancers to advance safer, less toxic therapies.